Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities. - Ikeda J; Shiba N; Kato S; Kunimoto H; Saito Y; Sagisaka M; Ito M; Goto H; Okuno Y; Nakamura W; Yoshitomi M; Takeuchi M; et al. (International journal of hematology, 2025)